[Hong Kong, 4 March 2016]  Hong Kong Applied Science and Technology Research Institute Company Limited (ASTRI) has announced the appointment of Mr Andy Liu, Vice Chairman of Hong Kong Biotechnology Organization, to the ASTRI Board for a term of two years with effect from 1 March 2016.

Mr Andy Liu has served as President of Asia Pacific and China for IMS Health, a TPG private equity portfolio company focusing on big data healthcare.   Mr Liu’s area of focus is commercialisation and M&A.  He has extensive experience in healthcare big data and healthcare technologies.

Furthermore, commencing 1 March 2016, three serving Directors of ASTRI, namely Mr Cheng Cheuk-wing, Prof Ching Pak-chung and Mr  Ha Yung-kuen have also been re-appointed for another two-year term.

Related News

China Mobile Hong Kong Partners with ASTRI and HKSTP to Accelerate Smart City Development in Hong Kong

First Network Provider in Hong Kong to Complete 5G Commercial Equipment Base Station Field Testing; ...

Secretary for Financial Services and the Treasury visits ASTRI and inspires its FinTech R&D team to continue the great work

The HKSAR Government’s Secretary for Financial Services and the Treasury, Honourable Mr James Lau, J ...

ASTRI’s R&D experts share latest developments in 3D Machine Vision at C-TOUCH & DISPLAY SHENZHEN 2018

Dr CJ Tsai, Director of Intelligent Sensing Technology System (ISTS) of ASTRI, was invited to share ...

ASTRI joins HKU Space to help build Hong Kong’s FinTech talent pipeline

Grooming the next generation of technology talents is one of the biggest challenges facing Hong Kong ...

ASTRI Inspires a Smarter Future Empowered by AI at the Technovation Summit 2018

Distinguished speakers from Government agencies, academia and the industry attended the annual forum ...